Intended for healthcare professionals

Latest dermatology news

 

Winners announced for QiC Dermatology 2021 in association with Dermatology in practice!

The awards took place at the Reading office of our sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.

24 Sep 2021

Recognition for Professor Hywel Williams in the Queen’s Birthday Honours

OBE awarded for his services to the national COVID-19 response

15 Jul 2021

NICE urges mental health support for people with acne

The guideline is the first from NICE to recommend mental health support for people with acne experiencing psychological distress 

 

15 Jul 2021

Bimekizumab gains positive CHMP opinion for plaque psoriasis

Positive CHMP opinion is based on results from three Phase III studies – BE VIVID, BE READY and BE SURE

15 Jul 2021

Sanofi, Regeneron's Libtayo cleared for basal cell carcinoma

Libtayo becomes the first immunotherapy indicated for patients with advanced basal cell carcinoma

25 Jun 2021

Guselkumab bags positive results in post-TNFi psoriatic arthritis patients

In the Phase IIIb COSMOS study, guselkumab helped patients to achieve complete skin clearance

22 Jun 2021

NICE backs guselkumab for the treatment of active psoriatic arthritis

Interleukin-23 inhibitor recommended for patients with moderate-to-severe disease

22 Jun 2021

Incyte's ruxolitinib cream shows promise in vitiligo

Data will support planned US and EU regulatory submissions for ruxolitinib cream in vitiligo in the second half of 2021

22 Jun 2021

80% of men failing to properly apply sun protection

A new study commissioned by Clarins shows only 20% of men apply sun protection cream daily as per the minimum requirements.

15 Jun 2021

MHRA approves new dosing of psoriasis therapy Skyrizi

Risankizumab (marketed as Skyrizi) can now be administered as one injection per dose, either by pre-filled pen or pre-filled syringe, to treat moderate to severe psoriasis in adults

15 Jun 2021
1234